{"name": "Tansna Therapeutics",
 "permalink": "tansna-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/tansna-therapeutics",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2010,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": null,
 "email_address": "",
 "phone_number": "",
 "description": "drug discovery and development",
 "created_at": "Tue Jun 04 17:47:06 UTC 2013",
 "updated_at": "Tue Jun 04 20:31:28 UTC 2013",
 "overview": "\u003Cp\u003ETansna is a drug discovery and development company founded in 2010 to create and commercialize oral drugs to treat epilepsy. Nearly 1 in 26 people will develop epilepsy in their lifetime. A significant need for more effective and safer antiepileptic drugs remains \u2013 indeed, approximately 30% of epilepsy patients are refractory, or unresponsive, to currently available therapeutics. Tansna has discovered novel compounds that are highly effective in several animal models of epilepsy, including refractory epilepsy.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       74],
      "assets/images/resized/0027/1196/271196v2-max-150x150.jpg"],
     [[250,
       124],
      "assets/images/resized/0027/1196/271196v2-max-250x250.jpg"],
     [[278,
       138],
      "assets/images/resized/0027/1196/271196v2-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.bizjournals.com/stlouis/blog/BizNext/2013/02/biogenerators-investment-means-tansna.html",
    "source_description": "St. Louis Business Journal",
    "raised_amount": null,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 2,
    "funded_day": 19,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BioGenerator",
         "permalink": "biogenerator",
         "image":
          {"available_sizes":
            [[[150,
               101],
              "assets/images/resized/0012/0644/120644v3-max-150x150.jpg"],
             [[215,
               146],
              "assets/images/resized/0012/0644/120644v3-max-250x250.jpg"],
             [[215,
               146],
              "assets/images/resized/0012/0644/120644v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4320 Forest Park",
    "address2": "",
    "zip_code": "63108",
    "city": "St. Louis",
    "state_code": "MO",
    "country_code": "USA",
    "latitude": 38.6391821,
    "longitude": -90.2619605}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}